Press release
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million by 2032 at a CAGR of 6.91% by 2032, Evaluates DelveInsight
DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices companies actively working in the market.
To know more about why North America is leading the market growth in the Transdermal Drug Delivery Devices market, get a snapshot of the report Transdermal Drug Delivery Devices Market Trends
https://www.delveinsight.com/sample-request/transdermal-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Transdermal Drug Delivery Devices Overview
Transdermal drug delivery devices are medical systems designed to deliver medications through the skin directly into the bloodstream. These devices, such as transdermal patches and microneedle systems, offer a non-invasive and controlled method of drug administration, ensuring steady absorption over time. They are commonly used for conditions requiring continuous medication delivery, such as pain management, hormone therapy, and cardiovascular diseases. By bypassing the digestive system, transdermal devices improve patient compliance, reduce side effects, and enhance drug efficacy through sustained and targeted delivery.
DelveInsight Analysis: The transdermal drug delivery devices market size was valued at USD 71,566.27 million in 2024 and is anticipated to grow at a CAGR of 6.91%, reaching approximately USD 121,798.76 million by 2032.
Transdermal Drug Delivery Devices Market Insights
Geographically, The North America transdermal drug delivery devices market is projected to account for the largest share 45.39% of the global market in 2024, growing at a CAGR of 6.91% from 2025 to 2032. This growth is primarily driven by the rising prevalence of targeted diseases such as chronic pain, cardiovascular conditions, and central nervous system disorders. Additionally, an increase in product launches and a strong emphasis on research and development activities are further supporting market expansion. Collectively, these factors position North America as a key contributor to the overall growth of the transdermal drug delivery devices market during the forecast period.
To read more about the latest highlights related to Transdermal Drug Delivery Devices, get a snapshot of the key highlights entailed in the Transdermal Drug Delivery Devices Insights
https://www.delveinsight.com/report-store/transdermal-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Transdermal Drug Delivery Devices Market Report
• In July 2024, Kindeva Drug Delivery's Woodbury, MN facility was FDA-inspected and classified. The facility now supports clients with integrated and stand-alone analytical services for pharmaceutical, biopharmaceutical, and medical device sectors.
• In March 2024, PassPort Technologies, Inc., a San Diego-based clinical-stage company, reported positive interim results from its Phase 1 trial of Zolmitriptan PassPort®, using a proprietary transdermal microporation system for acute migraine treatment. Zolmitriptan, an FDA-approved migraine medication, is tested for efficacy via this new delivery system.
• Thus, owing to such developments in the market, rapid growth will be observed in the Transdermal Drug Delivery Devices market during the forecast period
Key Players in the Transdermal Drug Delivery Devices Market
Some of the key market players operating in the Transdermal Drug Delivery Devices market include- Hisamitsu Pharmaceutical, Mylan, UCB SA, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, Purdue Pharma, Bristol-Myers Squibb Company, Endo Pharmaceuticals Inc., Acrux Limited, Lavipharm, Lead Chemicals Co. Inc., Luye Pharma Group and others.
Which MedTech key players in the Transdermal Drug Delivery Devices market are set to emerge as the trendsetter explore @ Key Transdermal Drug Delivery Devices Companies
https://www.delveinsight.com/sample-request/transdermal-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Transdermal Drug Delivery Devices Market Landscape
Drug-in-adhesive transdermal patches offer a non-invasive, convenient alternative to traditional drug delivery methods, eliminating the need for needles while ensuring patient comfort. These systems enable controlled, sustained medication release, maintaining consistent drug levels in the bloodstream over time. Additionally, the availability of key products such as TRANSDERM-V by Novartis and the Mylan-rivastigmine Patch 10 by Viatris Inc. further strengthens market growth.
Consequently, these advantages are expected to drive higher demand for drug-in-adhesive systems, contributing significantly to the overall expansion of the transdermal drug delivery devices market throughout the forecast period.
Scope of the Transdermal Drug Delivery Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Transdermal Drug Delivery Devices Market Segmentation By Type: Drug-in-adhesive Patches, Matrix Patches, Reservoir Membrane Patches, and Microneedle Patches
• Transdermal Drug Delivery Devices Market Segmentation By Application: Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Disorders, and Others
• Transdermal Drug Delivery Devices Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Transdermal Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Transdermal Drug Delivery Devices Companies: Hisamitsu Pharmaceutical, Mylan, UCB SA, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, Purdue Pharma, Bristol-Myers Squibb Company, Endo Pharmaceuticals Inc., Acrux Limited, Lavipharm, Lead Chemicals Co. Inc., Luye Pharma Group and others.
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Transdermal Drug Delivery Devices market will grow by 2032? Click to get a snapshot of the Transdermal Drug Delivery Devices Market Analysis
https://www.delveinsight.com/sample-request/transdermal-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million by 2032 at a CAGR of 6.91% by 2032, Evaluates DelveInsight here
News-ID: 4259444 • Views: …
More Releases from DelveInsight Business Research
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical…
Global Bone Graft and Substitute Market to reach USD 5,957.71 million by 2032 at …
According to DelveInsight's analysis, The global bone graft and substitutes market is witnessing significant growth due to the rising incidence of bone-related disorders and trauma cases, along with increasing demand for bone grafts in dental applications. Conditions such as osteoporosis and fractures are becoming more prevalent, especially among the aging population, driving the need for effective bone regeneration and repair solutions.
The expanding geriatric population, prone to bone degeneration and…
Global Active Implantable Medical Devices Market to reach USD 44,906.36 million …
According to DelveInsight's analysis, The growth of the global active implantable medical devices market is primarily fueled by the increasing prevalence of chronic diseases such as cardiovascular, neurological, and hearing disorders. Additionally, continuous technological advancements, rising awareness, and a stronger focus on early diagnosis are enhancing adoption rates and improving patient access to advanced implantable solutions worldwide.
DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
Corneal Edema Market in the US Projected for Significant Expansion from USD 489 …
DelveInsight's latest report on Corneal Edema forecasted significant growth in the US, driven by the emergence of new and effective treatments such as EO2002 ( Emmetrope Ophthalmics LLC), TTHX1114 (Trefoil Therapeutics), GLANATEC (D. Western Therapeutics Institute (DWTI)/Kowa Ltd.), STN1010904 (Santen Pharmaceutical) and others.
DelveInsight's latest report, "Corneal Edema: Market Insights, Epidemiology, and Market Forecast-2034," combines robust epidemiological data with corneal edema market trends, competitive landscape analysis, and patient journey assessments. The…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
